High Net Worth Advisory Group LLC Oncolytics Biotech Inc Transaction History

High Net Worth Advisory Group LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.85 - $1.59 $425 - $795	-500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.31 - $2.02 $655 - $1,010	500 New	500 $1,000

1.25M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $42.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.